Pharmasset Inc. (VRUS) Profile

Profile for Pharmasset Inc.  (VRUS) 
$ N/A N/A (N/A) Volume: N/A
Business Description:
Pharmasset, Inc. is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections.
Address: 303-A College Road. East, Princeton, NJ, 08540
Telephone: (609) 613-4100 Website: www.pharmasset.com
Facsimile: (609) 613-4150 Email: ir@pharmasset.com
Details
CEO: N/A
Employees: 82 Market Cap: N/A
Issue Type: CS
Auditor: Grant Thornton LLP
Last Audit: Unqualified
Indices: Drug Manufacturers - Other
Industry Classifications
Sector: Healthcare CIK: 0001301081
Industry: Drugs
Sub-Industry:    Drug Manufacturers - Other
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)   

Tags for Pharmasset Inc.

Research stocks or mutual funds related to Pharmasset Inc. by keywords or tags. Find companies that have a similar focus to VRUS. The keywords below have been associated to VRUS by either user submission or electronic means.

biotechnology company stock trading financial ratio analysis corporate financial starbucks stock information map chest financial annual report laminated world map corporate secretary software annual report pharmaceutical supplies corporate governance investor relations service pharmaceuticals jobs pharma license pepsi stock symbol novartis pharmaceuticals financial report corporate travel center pharmaceutical class stock report investor relations data map anaheim hotel board of directors role pharmaceutical sales pharma stock returns world map posters biotech corporation minsk street map Drugs annual report of company corporate annual report investor relations information pepsi stock stock market report financial stock report board of directors info starbucks stock symbol pharmaceutical article pfizer pharmaceuticals pepsi annual report pharmaceutical events biotech investment board of directors responsibility pharmaceutical sale pharmaceutical business development Healthcare oil and gas investments bio pharmaceuticals